Analysis on the Treatment of Trimetazidine Jointed with Metoprolol in the Coronary Heart Disease with the Heart Failure

DOI

10.2991/bme-15.2015.9How to use a DOI?

Keywords

Coronary heart disease (CHD); Heart failure; Trimetazidine; Metoprolol

Abstract

Abstract. Objective: To observe and analyze the curative effect of the Trimetazidine joint with Metoprolol in the patients with heart failure and coronary heart disease, the treatment of patients with coronary heart disease with heart failure to provide certain reference. Methods: From May 2013 to May 2014, 76 cases of coronary heart disease with heart failure patients are divided into two groups by random method. Two groups of patients were given comprehensive treatment, the control group 38 patients on the basis of the given Trimetazidine treatment, treatment group on the basis of Trimetazidine with Metoprolol therapy. Results: After treatment, the treatment group therapy effect and improve cardiac function were significantly better than that in control group (P < 0.05). Conclusions: In patients with coronary heart disease with heart failure on the basis of conventional treatment with Trimetazidine joint with Metoprolol, the function and effect is very good, and is worthy of clinical popularization and application.

Copyright

© 2015, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Lingdong Meng
AU  - Yuntao Cheng
PY  - 2015/09
DA  - 2015/09
TI  - Analysis on the Treatment of Trimetazidine Jointed with Metoprolol in the Coronary Heart Disease with the Heart Failure
BT  - Proceedings of the 2015 International Forum on Bioinformatics and Medical Engineering
PB  - Atlantis Press
SP  - 46
EP  - 51
SN  - 2352-5401
UR  - https://doi.org/10.2991/bme-15.2015.9
DO  - 10.2991/bme-15.2015.9
ID  - Meng2015/09
ER  -